Intraocular Lens Injectors Market Share

  • Report ID: 6032
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Intraocular Lens Injectors Industry - Regional Synopsis

North American Market Statistics

North America industry is poised to account for largest revenue share of 30% by 2037. The growing cases of ophthalmic disorders and the increasing number of ophthalmologists are also estimated to rise.

Furthermore, the consumption of alcohol has surged significantly which is further boosting the prevalence of diabetes which gives rise to diabetic retinopathy leading to vision loss and blindness in individuals. As per the Centers for Disease Control and Prevention indicates that over 9.6 million Americans were affected by diabetic retinopathy in 2021. 

US - Moreover, the US is predicted to have the presence of key players in the field of AI and machine learning which is further encouraging collaboration with the healthcare sector. Hence, this factor is estimated to boost the overall growth of the intraocular lens injectors industry in North America.

Canada - There have been rising government initiatives in the form of investment and campaigns to spread awareness regarding the prevalence of eye disease and they are also offering treatment for the same. The Government of Canada is foreseen to invest over USD 26 million from the Canadian Institutes of Health Research (CIHR) and partners to innovate integrated health care.

APAC Market Analysis

The Asia Pacific intraocular lens injectors market is expected to have notable growth in revenue which is set to reach USD 1.20 billion by the end of 2036. This rise is poised to be encouraged by the increasing urban population, and the associated several eye diseases. Over 2.2 billion individuals across the globe are currently residing in the region of Asia.  Moreover, it is anticipated that this estimation in urban regions of Asia might grow by 50%.

China - Additionally, the market in China is evaluated to have significant growth in the Asia Pacific region owing to the growing popularity and production of disposable intraocular lens injectors.  

Japan - The rising income of the employees in Japan is further encouraging their spending on eye surgery. 

Korea - The growing implantation of multifocal intraocular lens is estimated to have a significant influence on the intraocular lens injectors market in Korea. 

Intraocular Lens Injectors Market shares

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intraocular lens injectors is assessed at USD 17.16 billion.

The intraocular lens injectors market size was over USD 16.43 billion in 2024 and is projected to reach USD 31.76 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by growing prevalence of cataracts.

North America industry is poised to account for largest revenue share of 30% by 2037, influenced by growing prevalence ophthalmic disorders in the region.

The major players in the market are SpyGlass Pharma, Alcon, Bausch Health Companies, Inc., Carl Zeiss AG, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos